Revising a test suite using diagnostic efficacy evaluation

Details Revising a test suite using diagnostic efficacy evaluation Revising a test suite using diagnostic efficacy evaluation

2006-11-21

2006-11-21

Bui, Bryan (Department: 2863)

Data processing: measuring, calibrating, or testing

Measurement system

Performance or efficiency evaluation

C702S081000, C702S123000, C714S026000, C714S033000

Reexamination Certificate

active

07139676

ABSTRACT:
A method and a system evaluate an efficacy of a test suite in a model-based diagnostic testing system to determine a revision of the test suite. The evaluation comprises suggesting a test to be added to the test suite based on probabilities of a correct diagnosis and an incorrect diagnosis. The evaluation either alternatively or further comprises identifying a test to be deleted from the test suite based on probabilities of a correct diagnosis for the test suite and for a modified test suite that does not include a test. An efficacy value of each test in the test suite is computed. The system has a computer program comprising instructions that implement an evaluation of diagnostic efficacy of the test suite. The system either is a stand-alone system or is incorporated into the testing system.

REFERENCES:
patent: 5130936 (1992-07-01), Sheppard et al.
patent: 5544308 (1996-08-01), Giordano et al.
patent: 5808919 (1998-09-01), Preist et al.
patent: 5922079 (1999-07-01), Booth et al.
patent: 6167352 (2000-12-01), Kanevsky et al.
patent: 0 887 733 (1998-06-01), None
patent: 1 136 912 (2001-01-01), None
Daniel Bell et al—Using Causal Reasoning for Automated Failure Modes and Effects Analysis (FMEA); Reliability and Maintainability Symposium, 1992; Proceedings, Annual Las Vegas, Nevada, USA, Jan. 21-23, 1992; New York, NY, USA, IEEE, US; Jan. 21, 1992, pp. 343-353, XP010058370; ISBN: 0-7803-0521-3.
Chrysler Corporation, Ford Motor Company, General Motors Corporation: “Potential Failure Mode and Effects Analysis (FMEA)—Reference Manual”; 1995, Carwin Continuous Ltd., Essex, England XP002240667; pp. 27-45, 51, 53.
European Search Report dated May 9, 2003—2Pages.

Affiliated with

Also associated with

Rating

Revising a test suite using diagnostic efficacy evaluation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Revising a test suite using diagnostic efficacy evaluation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Revising a test suite using diagnostic efficacy evaluation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3621911